search
Back to results

Dexamethasone Preoperative for Patients Undergoing Laparoscopy for Suspected Appendicitis

Primary Purpose

Suspected Appendicitis

Status
Completed
Phase
Phase 2
Locations
Denmark
Study Type
Interventional
Intervention
dexamethasone phosphate
Isotonic NaCl
Sponsored by
Nordsjaellands Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Suspected Appendicitis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Scheduled for a diagnostic laparoscopy for suspected appendicitis
  • ASA clas I-III

Exclusion Criteria:

  • Known inflammatory bowel disease
  • Known autoimmune disease.
  • Chronic pain patient.
  • Pregnant or breastfeeding.
  • In treatment with systemic corticoid steroids or immune-depressants.
  • Known glaucoma.
  • Known ocular herpes simplex.
  • Vaccination within 14 days prior to inclusion.
  • Known cushing's disease.
  • Known myasthenia gravis.
  • Presumably poor compliance with study protocol.

Sites / Locations

  • Kirurgisk afdeling, Nordsjællands Hospital
  • Kirurgisk afdeling, Køge sygehus

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Experimental

Arm Label

Placebo

dexamethasone

Arm Description

Injection of 2 ml isotonic NaCl intravenously minimum 30 minutes preoperative.

Injection of 2 ml 4 mg/ml dexamethasone phosphate intravenously minimum 30 minutes preoperative.

Outcomes

Primary Outcome Measures

Postoperative nausea and vomiting (PONV)
Incidents of nausea and/or vomiting during the first 24-32 hours postoperative

Secondary Outcome Measures

Pain at rest (VAS scale)
Pain at rest measured on a 100 mm VAS scale
Pain when coughing (VAS scale)
Pain when coughing measured on a 100 mm VAS scale
Postoperative fatigue (VAS scale)
Postoperative fatigue measured on a 100 mm VAS scale
Quality of recovery (QoR-15D questionnaire)
Quality of recovery measured by the QoR-15D questionnaire
Time until resumption of normal daily activities
Time until resumption of normal daily activities and reason for not resuming activities earlier
Time until resumption of work
Time until resumption of work and reason for not resuming work earlier
Sleep quality (VAS scale)
Quality of sleep measured on a 100 mm VAS scale
Postoperative complications (Clavien-Dindo classification of surgical complications)
30 days postoperative complication according to the Clavien-Dindo classification of surgical complications
Duration of admission
Duration of primary admission
PONV
PONV
PONV
Pain at rest (VAS scale)
Pain at rest measured on a 100 mm VAS scale
Pain at rest (VAS scale)
Pain at rest measured on a 100 mm VAS scale
Pain at rest (VAS scale)
Pain at rest measured on a 100 mm VAS scale
Pain at rest (VAS scale)
Pain at rest measured on a 100 mm VAS scale
Pain at rest (VAS scale)
Pain at rest measured on a 100 mm VAS scale
Pain at rest (VAS scale)
Pain at rest measured on a 100 mm VAS scale
Pain at rest (VAS scale)
Pain at rest measured on a 100 mm VAS scale
Pain when coughing (VAS scale)
Pain when coughing measured on a 100 mm VAS scale
Pain when coughing (VAS scale)
Pain when coughing measured on a 100 mm VAS scale
Pain when coughing (VAS scale)
Pain when coughing measured on a 100 mm VAS scale
Pain when coughing (VAS scale)
Pain when coughing measured on a 100 mm VAS scale
Pain when coughing (VAS scale)
Pain when coughing measured on a 100 mm VAS scale
Pain when coughing (VAS scale)
Pain when coughing measured on a 100 mm VAS scale
Pain when coughing (VAS scale)
Pain when coughing measured on a 100 mm VAS scale
Postoperative fatigue (VAS scale)
Postoperative fatigue measured on a 100 mm VAS scale
Postoperative fatigue (VAS scale
Postoperative fatigue measured on a 100 mm VAS scale
Postoperative fatigue (VAS scale
Postoperative fatigue measured on a 100 mm VAS scale
Postoperative fatigue (VAS scale
Postoperative fatigue measured on a 100 mm VAS scale
Postoperative fatigue (VAS scale
Postoperative fatigue measured on a 100 mm VAS scale
Postoperative fatigue (VAS scale
Postoperative fatigue measured on a 100 mm VAS scale
Postoperative fatigue (VAS scale
Postoperative fatigue measured on a 100 mm VAS scale
Quality of recovery (QoR-15D questionnaire)
Quality of recovery measured by the QoR-15D questionnaire
Quality of recovery (QoR-15D questionnaire)
Quality of recovery measured by the QoR-15D questionnaire
Quality of recovery (QoR-15D questionnaire)
Quality of recovery measured by the QoR-15D questionnaire
Quality of recovery (QoR-15D questionnaire)
Quality of recovery measured by the QoR-15D questionnaire
Quality of recovery (QoR-15D questionnaire)
Quality of recovery measured by the QoR-15D questionnaire
Sleep quality (VAS scale)
Quality of sleep measured on a 100 mm VAS scale
Sleep quality (VAS scale)
Quality of sleep measured on a 100 mm VAS scale
Sleep quality (VAS scale)
Quality of sleep measured on a 100 mm VAS scale
Sleep quality (VAS scale)
Quality of sleep measured on a 100 mm VAS scale
Sleep quality (VAS scale)
Quality of sleep measured on a 100 mm VAS scale

Full Information

First Posted
March 31, 2015
Last Updated
February 22, 2016
Sponsor
Nordsjaellands Hospital
Collaborators
Zealand University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02415335
Brief Title
Dexamethasone Preoperative for Patients Undergoing Laparoscopy for Suspected Appendicitis
Official Title
Dexamethasone Preoperative for Patients Undergoing Laparoscopy for Suspected Appendicitis
Study Type
Interventional

2. Study Status

Record Verification Date
February 2016
Overall Recruitment Status
Completed
Study Start Date
April 2015 (undefined)
Primary Completion Date
October 2015 (Actual)
Study Completion Date
October 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Nordsjaellands Hospital
Collaborators
Zealand University Hospital

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
For elective abdominal surgery preoperative administration of 8 mg dexamethasone reduces the incidents of postoperative nausea and vomiting (PONV). Whether preoperative administration of 8 mg dexamethasone reduces PONV for patients having acute abdominal surgery has not been established. The investigators wish to see if preoperative administration of 8 mg dexamethasone minimum 30 minutes prior to a diagnostic laparoscopy for suspected appendicitis will reduce the incidents of PONV by 50%. Of secondary interest the investigators want to see if 8 mg dexamethasone preoperative can reduce pain, reduce opioid consumption, postoperative fatigue, duration of time until resumption of work and resumption of normal daily activities, and enhanced the quality of recovery.
Detailed Description
Eligible patients undergoing a diagnostic laparoscopy for suspected appendicitis will be randomized to receive placebo or 8 mg dexamethasone intravenously minimum 30 minutes prior to the operation. Randomization will be done by envelope randomization. We would expect that 60% of the patients would experience postoperative nausea or vomiting (PONV) during the first 24-32 hours postoperatively. To show a 50% reduction in the incidents of PONV during the first 24-32 hours postoperatively (with a power of 80%, a significant level of 5% and a loss to follow up of 20%) we need 60 patients in each arm. So a total of 120 patients are to be randomized 1:1. Both sites use paper Case Report Forms (CRF). The trial will be monitored by the regional GCP (Good Clinical Practice) unit and adhere to GCP guidelines. Patients are assessed by self reporting questionnaires preoperatively and postoperatively after 2-10 hours, 8-16 hours, 24-32 hours, on postoperative day (POD) 2, POD 3, POD 7, POD 14 and POD 30. Preoperative anxiety recorded by a VAS scale, Pain Catastrophizing Scale and Hospital anxiety and depression scale are recorded by the preoperative questionnaire. A short telephone interview will be done during the first postoperative day regarding duration of abdominal pain prior to admission, social status regarding children and whether they living with another adult, smoking status, use of sleep medication or use of psychopharmacy a minimum of 7 days prior to the operation, physical level of normal daily activities, physical level of work, educational and occupational background. Other demographics such as height, weight, ASA class, age, last CRP prior to the operation, duration of the operation, date and time of admission, date and time of discharge are registered through the electronic patient record files. Pathology of any removed tissue are registered trough the pathology report. Diagnosis at the operation, preformed procedure, whether the preforming surgeon was supervised, number of identical procedures preformed previous by the surgeon or the surgeons supervisor (if supervised) will be recorded in the patients CRF by the preforming surgeon. Pre-, intra- and post-operative pain medication, antiemetics and antibiotics are recorded through the electronic patient medication files. Postoperative complications and adverse events are recorded through the electronic patient record files and by telephone interview. To ensure a high completion rate, patients are contacted by telephone at each registration time postoperatively. Parametric or non-parametric statistical analysis will be used when appropriate.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Suspected Appendicitis

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
119 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Injection of 2 ml isotonic NaCl intravenously minimum 30 minutes preoperative.
Arm Title
dexamethasone
Arm Type
Experimental
Arm Description
Injection of 2 ml 4 mg/ml dexamethasone phosphate intravenously minimum 30 minutes preoperative.
Intervention Type
Drug
Intervention Name(s)
dexamethasone phosphate
Other Intervention Name(s)
Dexamethasone
Intervention Description
Intravenously administration minimum of 30 minutes preoperatively.
Intervention Type
Drug
Intervention Name(s)
Isotonic NaCl
Other Intervention Name(s)
Placebo
Intervention Description
Intravenously administration minimum of 30 minutes preoperatively
Primary Outcome Measure Information:
Title
Postoperative nausea and vomiting (PONV)
Description
Incidents of nausea and/or vomiting during the first 24-32 hours postoperative
Time Frame
24-32 hours postoperative
Secondary Outcome Measure Information:
Title
Pain at rest (VAS scale)
Description
Pain at rest measured on a 100 mm VAS scale
Time Frame
2-10 hours postoperative
Title
Pain when coughing (VAS scale)
Description
Pain when coughing measured on a 100 mm VAS scale
Time Frame
2-10 hours postoperative
Title
Postoperative fatigue (VAS scale)
Description
Postoperative fatigue measured on a 100 mm VAS scale
Time Frame
2-10 hours postoperative
Title
Quality of recovery (QoR-15D questionnaire)
Description
Quality of recovery measured by the QoR-15D questionnaire
Time Frame
24-32 hours postoperative
Title
Time until resumption of normal daily activities
Description
Time until resumption of normal daily activities and reason for not resuming activities earlier
Time Frame
Registration when resumption, expected to be within 60 days postoperatively
Title
Time until resumption of work
Description
Time until resumption of work and reason for not resuming work earlier
Time Frame
Registration when resumption, expected to be within 60 days postoperatively
Title
Sleep quality (VAS scale)
Description
Quality of sleep measured on a 100 mm VAS scale
Time Frame
24-32 hours postoperative
Title
Postoperative complications (Clavien-Dindo classification of surgical complications)
Description
30 days postoperative complication according to the Clavien-Dindo classification of surgical complications
Time Frame
30 days postoperative
Title
Duration of admission
Description
Duration of primary admission
Time Frame
30 days
Title
PONV
Time Frame
2-10 hours postoperatively
Title
PONV
Time Frame
8-16 hours postoperatively
Title
PONV
Time Frame
24-32 hours postoperatively
Title
Pain at rest (VAS scale)
Description
Pain at rest measured on a 100 mm VAS scale
Time Frame
8-16 hours postoperative
Title
Pain at rest (VAS scale)
Description
Pain at rest measured on a 100 mm VAS scale
Time Frame
24-32 hours postoperative
Title
Pain at rest (VAS scale)
Description
Pain at rest measured on a 100 mm VAS scale
Time Frame
POD (Post Operative Day) 2
Title
Pain at rest (VAS scale)
Description
Pain at rest measured on a 100 mm VAS scale
Time Frame
POD3
Title
Pain at rest (VAS scale)
Description
Pain at rest measured on a 100 mm VAS scale
Time Frame
POD7
Title
Pain at rest (VAS scale)
Description
Pain at rest measured on a 100 mm VAS scale
Time Frame
POD14
Title
Pain at rest (VAS scale)
Description
Pain at rest measured on a 100 mm VAS scale
Time Frame
POD30
Title
Pain when coughing (VAS scale)
Description
Pain when coughing measured on a 100 mm VAS scale
Time Frame
8-16 hours postoperative
Title
Pain when coughing (VAS scale)
Description
Pain when coughing measured on a 100 mm VAS scale
Time Frame
24-42 hours postoperative
Title
Pain when coughing (VAS scale)
Description
Pain when coughing measured on a 100 mm VAS scale
Time Frame
POD2
Title
Pain when coughing (VAS scale)
Description
Pain when coughing measured on a 100 mm VAS scale
Time Frame
POD3
Title
Pain when coughing (VAS scale)
Description
Pain when coughing measured on a 100 mm VAS scale
Time Frame
POD7
Title
Pain when coughing (VAS scale)
Description
Pain when coughing measured on a 100 mm VAS scale
Time Frame
POD14
Title
Pain when coughing (VAS scale)
Description
Pain when coughing measured on a 100 mm VAS scale
Time Frame
POD30
Title
Postoperative fatigue (VAS scale)
Description
Postoperative fatigue measured on a 100 mm VAS scale
Time Frame
8-16 hours postoperative
Title
Postoperative fatigue (VAS scale
Description
Postoperative fatigue measured on a 100 mm VAS scale
Time Frame
24-32 hours postoperative
Title
Postoperative fatigue (VAS scale
Description
Postoperative fatigue measured on a 100 mm VAS scale
Time Frame
POD2
Title
Postoperative fatigue (VAS scale
Description
Postoperative fatigue measured on a 100 mm VAS scale
Time Frame
POD3
Title
Postoperative fatigue (VAS scale
Description
Postoperative fatigue measured on a 100 mm VAS scale
Time Frame
POD7
Title
Postoperative fatigue (VAS scale
Description
Postoperative fatigue measured on a 100 mm VAS scale
Time Frame
POD14
Title
Postoperative fatigue (VAS scale
Description
Postoperative fatigue measured on a 100 mm VAS scale
Time Frame
POD30
Title
Quality of recovery (QoR-15D questionnaire)
Description
Quality of recovery measured by the QoR-15D questionnaire
Time Frame
POD2
Title
Quality of recovery (QoR-15D questionnaire)
Description
Quality of recovery measured by the QoR-15D questionnaire
Time Frame
POD3
Title
Quality of recovery (QoR-15D questionnaire)
Description
Quality of recovery measured by the QoR-15D questionnaire
Time Frame
POD7
Title
Quality of recovery (QoR-15D questionnaire)
Description
Quality of recovery measured by the QoR-15D questionnaire
Time Frame
POD14
Title
Quality of recovery (QoR-15D questionnaire)
Description
Quality of recovery measured by the QoR-15D questionnaire
Time Frame
POD30
Title
Sleep quality (VAS scale)
Description
Quality of sleep measured on a 100 mm VAS scale
Time Frame
POD2
Title
Sleep quality (VAS scale)
Description
Quality of sleep measured on a 100 mm VAS scale
Time Frame
POD3
Title
Sleep quality (VAS scale)
Description
Quality of sleep measured on a 100 mm VAS scale
Time Frame
POD7
Title
Sleep quality (VAS scale)
Description
Quality of sleep measured on a 100 mm VAS scale
Time Frame
POD14
Title
Sleep quality (VAS scale)
Description
Quality of sleep measured on a 100 mm VAS scale
Time Frame
POD30
Other Pre-specified Outcome Measures:
Title
Mobilisation postoperative (Ability to get out of bed)
Description
Ability to get out of bed
Time Frame
2-10 hours postoperative
Title
Pain localization (Localization of postoperative pain)
Description
Localization of postoperative pain
Time Frame
2-10 hours postoperative
Title
Adverse events
Description
AE, AR, SAR and SUSARS
Time Frame
30 days
Title
Mobilisation postoperative (Ability to get out of bed)
Description
Ability to get out of bed
Time Frame
8-16 hours postoperative
Title
Mobilisation postoperative (Ability to get out of bed)
Description
Ability to get out of bed
Time Frame
24-32 hours postoperative
Title
Pain localization (Localization of postoperative pain)
Description
Localization of postoperative pain
Time Frame
8-16 hours postoperative
Title
Pain localization (Localization of postoperative pain)
Description
Localization of postoperative pain
Time Frame
24-32 hours postoperative
Title
Pain localization (Localization of postoperative pain)
Description
Localization of postoperative pain
Time Frame
POD2
Title
Pain localization (Localization of postoperative pain)
Description
Localization of postoperative pain
Time Frame
POD3
Title
Pain localization (Localization of postoperative pain)
Description
Localization of postoperative pain
Time Frame
POD7
Title
Pain localization (Localization of postoperative pain)
Description
Localization of postoperative pain
Time Frame
POD14
Title
Pain localization (Localization of postoperative pain)
Description
Localization of postoperative pain
Time Frame
POD30

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Scheduled for a diagnostic laparoscopy for suspected appendicitis ASA clas I-III Exclusion Criteria: Known inflammatory bowel disease Known autoimmune disease. Chronic pain patient. Pregnant or breastfeeding. In treatment with systemic corticoid steroids or immune-depressants. Known glaucoma. Known ocular herpes simplex. Vaccination within 14 days prior to inclusion. Known cushing's disease. Known myasthenia gravis. Presumably poor compliance with study protocol.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jakob Kleif, M.D.
Organizational Affiliation
Nordsjaellands Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kirurgisk afdeling, Nordsjællands Hospital
City
Hillerød
ZIP/Postal Code
3400
Country
Denmark
Facility Name
Kirurgisk afdeling, Køge sygehus
City
Køge
ZIP/Postal Code
4600
Country
Denmark

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
29605019
Citation
Kleif J, Gogenur I. Severity classification of the quality of recovery-15 score-An observational study. J Surg Res. 2018 May;225:101-107. doi: 10.1016/j.jss.2017.12.040. Epub 2018 Feb 21.
Results Reference
derived
PubMed Identifier
28072446
Citation
Kleif J, Kirkegaard A, Vilandt J, Gogenur I. Randomized clinical trial of preoperative dexamethasone on postoperative nausea and vomiting after laparoscopy for suspected appendicitis. Br J Surg. 2017 Mar;104(4):384-392. doi: 10.1002/bjs.10418. Epub 2017 Jan 10.
Results Reference
derived

Learn more about this trial

Dexamethasone Preoperative for Patients Undergoing Laparoscopy for Suspected Appendicitis

We'll reach out to this number within 24 hrs